Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

First Edition

Research Article September 19 2025
Reprogramming glutamine metabolism enhances BCMA-CART cell fitness and therapeutic efficacy in multiple myeloma
Research Article September 19 2025
VEXAS syndrome anemia is a mosaic erythroblastopenia
Letter September 19 2025
FLAG-IDA plus venetoclax for children, adolescents, and young adults with newly diagnosed AML
Research Article September 19 2025
The watch-and-wait approach for patients with juvenile myelomonocytic leukemia: results of the French cohort
Review Article September 17 2025
Drug development in MZL: caring for the forgotten child
Research Article September 17 2025
Rbm38 Deficiency Impairs Erythroid Heme Biosynthesis and Induces Porphyria via Reduced Ferrochelatase Expression
Research Article September 17 2025
A genome-wide screen identifies Runx2 as a novel regulator of hematopoietic stem cell expansion and T-cell commitment
Research Article September 17 2025
Sclerotic GVHD and Scleroderma Share Dysregulated Gene Expression that is Ameliorated by EREG Therapeutic Antibody
Letter September 12 2025
Human herpesvirus 6 viremia and encephalitis in CAR T-cell recipients
Brief Report September 12 2025
Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial
Research Article September 12 2025
Targeting STK17B kinase activates ferroptosis and suppresses drug resistance in multiple myeloma
Research Article September 9 2025
Isatuximab for Relapsed and/or Refractory AL Amyloidosis: Results of a Prospective Phase 2 Trial (SWOG S1702)
Brief Report September 9 2025
Intestinal hepcidin overexpression promotes iron deficiency anemia and counteracts iron overload via DMT1 downregulation
Research Article September 8 2025
Nuclear respiratory factor 1 promotes cell survival in multiple myeloma under proteasome inhibition therapy
Research Article September 8 2025
Fixed-Duration Epcoritamab Plus R2 Drives Favorable Outcomes in Relapsed or Refractory Follicular Lymphoma
Research Article September 8 2025
CUX1 restrains latent hematopoietic stem cell plasticity by suppressing stem cell-intrinsic inflammatory pathways
Research Article September 8 2025
Platelet Factor 4 (PF4) Regulates Hematopoietic Stem Cell Aging
Research Article September 4 2025
Leukemia escapes immunity by imposing a type 1 regulatory program on neoantigen-specific CD4+ T cells
Research Article September 4 2025
Innate lymphoid cells prevent graft-versus-host disease via IL-9-driven T-cell senescence
Research Article September 4 2025
Acalabrutinib treatment for older (≥80 years old) and/or frail patients with CLL: primary end point analysis of the CLL-Frail trial
Review Article September 4 2025
Platelet heterogeneity in disease: the many and the diverse?
Research Article September 4 2025
A bispecific nanobody for the treatment of von Willebrand disease type 1
Research Article September 3 2025
Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemia
Research Article September 2 2025
The Origin, Diagnosis, and Prognosis of Oligomannose-Type Diffuse Large B-Cell Lymphoma
Research Article September 2 2025
Nanoromidepsin, a Polymer Nanoparticle of the HDAC Inhibitor, Improves Safety and Efficacy in Models of T-cell Lymphoma
Research Article September 2 2025
Impact of ASXL1 at diagnosis in patients with CML receiving frontline potent TKIs: high risk of kinase domain mutations
Research Article August 27 2025
Targeting FXR in Hepatocytes: A Promising Approach to Enhance Fibrinolysis and Reduce Deep Vein Thrombosis Risk
Research Article August 27 2025
The impact of fitness and dose intensity on clinical outcomes with venetoclax-obinutuzumab in CLL
Research Article August 27 2025
CD371-Targeted CAR T cells Secreting Interleukin-18 Exhibit Robust Expansion and Clear Refractory Acute Myeloid Leukemia
Research Article August 27 2025
An immunostimulatory CELMoD combination overcomes resistance to T-cell engagers caused by a high multiple myeloma burden
Research Article August 27 2025
Long term follow-up outcomes in congenital thrombotic thrombocytopenic purpura
Review Article August 26 2025
Platelet Heterogeneity: Variety Makes Immune and Vascular Function Better
Research Article August 26 2025
Chronic NK cell activation results in a dysfunctional, tissue resident-like state mediated by KLF2 deficiency
Brief Report August 26 2025
A prime editing strategy to rewrite the γ-globin promoters and reactivate fetal hemoglobin for sickle cell disease
Review Article August 26 2025
Novel Strategies Targeting Mutant Calreticulin in Essential Thrombocythemia and Myelofibrosis
Brief Report August 26 2025
Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemia
Research Article August 26 2025
LEF1 Intragenic Deletion Induces a Dominant-Negative isoform and unveils a Wnt/β3-Catenin Vulnerability in T-ALL
Review Article August 22 2025
Remestemcel-L-rknd (Ryoncil): the first approved cellular therapy for steroid-refractory acute GVHD
Research Article August 22 2025
Mitochondrial DNA via recipient TLR9 acts as a potent first-hit in murine transfusion-related acute lung injury (TRALI)
Research Article August 22 2025
F8 gene variants influence the response to desmopressin in hemophilia A carriers
Review Article August 22 2025
Artificial Intelligence in Hematology
Research Article August 20 2025
Factor VIIa-released extracellular vesicles attenuate joint bleed-induced hemophilic arthropathy
Discussion August 20 2025
Gene Therapy for HbSC Disease and other Compound Heterozygous Sickle Hemoglobinopathies: A Time for Inclusion
Research Article August 20 2025
Challenging the Concept of Functional High-Risk Myeloma through Transcriptional and Genetic Profiling
Research Article August 19 2025
Layilin inhibits integrin activation, and its loss results in platelet hyperactivation via Rac1 in inflammatory bowel disease
Research Article August 19 2025
A T-cell-based metric of immune age predicts outcomes in older patients with myeloma receiving daratumumab-based therapy
Research Article August 19 2025
A phase 2 study of zanubrutinib in combination with rituximab and lenalidomide in de novo diffuse large B-cell lymphoma
Research Article August 19 2025
Proteomic subtypes enrich current acute myeloid leukemia nomenclature and reflect intrinsic pathogenesis alongside aging
Research Article August 18 2025
Epigenetic changes by EZH2 inhibition increase translocations in B cells with high AID activity or DNA repair deficiency
Review Article August 14 2025
Treatment of Relapsed and Refractory Follicular Lymphoma: Which Treatment for Which Patient for Which Line of Therapy?
Page 1 of 3

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals